Journal article icon

Journal article

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Abstract:

BACKGROUND: Throughout the usual LDL cholesterol range in Western populations, lower blood concentrations are associated with lower cardiovascular disease risk. In such populations, therefore, reducing LDL cholesterol may reduce the development of vascular disease, largely irrespective of initial cholesterol concentrations. METHODS: 20,536 UK adults (aged 40-80 years) with coronary disease, other occlusive arterial disease, or diabetes were randomly allocated to receive 40 mg simvastatin dail...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Heart Protection Study Collaborative Group More by this author
Journal:
Lancet
Volume:
360
Issue:
9326
Pages:
7-22
Publication date:
2002-07-05
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
URN:
uuid:fa05c262-9880-489a-bb24-792f8dcf3796
Source identifiers:
38300
Local pid:
pubs:38300

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP